Simply Wall St.
Thermo Fisher’s New Asia Bioprocessing Network Might Change The Case For Investing In Thermo Fisher Scientific (TMO)
📊
AI Sentiment
Positive
7/10
- Home
- TMO
as of 12-05-2025 3:43pm EST
$572.78
$2.46
-0.43%
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
Chart Type:
Time Range:
| Founded: | 1956 | Country: | United States |
| Employees: | N/A | City: | WALTHAM |
| Market Cap: | 216.4B | IPO Year: | N/A |
| Target Price: | $615.47 | AVG Volume (30 days): | 1.7M |
| Analyst Decision: | Buy | Number of Analysts: | 18 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 17.32 | EPS Growth: | 8.54 |
| 52 Week Low/High: | $385.46 - $610.97 | Next Earning Date: | 10-22-2025 |
| Revenue: | $43,736,000,000 | Revenue Growth: | 3.22% |
| Revenue Growth (this year): | 4.33% | Revenue Growth (next year): | 4.94% |
AI-Powered TMO Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 3 days ago
AI Recommendation
hold
Model Accuracy: 71.81%
71.81%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Thermo Fisher Scientific Inc (TMO)
Lagarde Michel
Sell
Executive Vice President & COO
TMO Dec 3, 2025
Avg Cost/Share
$583.72
Shares
32,000
Total Value
$18,668,526.38
Owned After
65,479.909
Lowery Frederick M.
Sell
Executive Vice President
TMO Dec 2, 2025
Avg Cost/Share
$581.94
Shares
6,912
Total Value
$4,022,369.28
Owned After
14,367.372
SEC Form 4
Lagarde Michel
Sell
Executive Vice President & COO
TMO Dec 2, 2025
Avg Cost/Share
$581.92
Shares
30,000
Total Value
$17,457,600.00
Owned After
65,479.909
SEC Form 4
Lowery Frederick M.
Sell
Executive Vice President
TMO Dec 1, 2025
Avg Cost/Share
$597.68
Shares
6,913
Total Value
$4,131,761.84
Owned After
14,367.372
SEC Form 4
Lagarde Michel
Sell
Executive Vice President & COO
TMO Nov 13, 2025
Avg Cost/Share
$594.42
Shares
4,638
Total Value
$2,756,919.96
Owned After
65,479.909
SEC Form 4
Britt Lisa P.
Sell
Sr. VP and Chief HR Officer
TMO Nov 12, 2025
Avg Cost/Share
$588.27
Shares
1,057
Total Value
$622,135.53
Owned After
13,087.227
SEC Form 4
Pettiti Gianluca
Sell
Executive Vice President
TMO Nov 10, 2025
Avg Cost/Share
$580.00
Shares
2,975
Total Value
$1,725,500.00
Owned After
21,152.223
Britt Lisa P.
Sell
Sr. VP and Chief HR Officer
TMO Nov 7, 2025
Avg Cost/Share
$571.53
Shares
10,225
Total Value
$5,844,850.07
Owned After
13,087.227
CASPER MARC N
Sell
Chairman & CEO
TMO Oct 27, 2025
Avg Cost/Share
$566.71
Shares
7,250
Total Value
$4,104,241.78
Owned After
116,019.285
CASPER MARC N
Sell
Chairman & CEO
TMO Oct 24, 2025
Avg Cost/Share
$573.23
Shares
17,104
Total Value
$9,809,862.02
Owned After
116,019.285
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Lagarde Michel | TMO | Executive Vice President & COO | Dec 3, 2025 | Sell | $583.72 | 32,000 | $18,668,526.38 | 65,479.909 | |
| Lowery Frederick M. | TMO | Executive Vice President | Dec 2, 2025 | Sell | $581.94 | 6,912 | $4,022,369.28 | 14,367.372 | |
| Lagarde Michel | TMO | Executive Vice President & COO | Dec 2, 2025 | Sell | $581.92 | 30,000 | $17,457,600.00 | 65,479.909 | |
| Lowery Frederick M. | TMO | Executive Vice President | Dec 1, 2025 | Sell | $597.68 | 6,913 | $4,131,761.84 | 14,367.372 | |
| Lagarde Michel | TMO | Executive Vice President & COO | Nov 13, 2025 | Sell | $594.42 | 4,638 | $2,756,919.96 | 65,479.909 | |
| Britt Lisa P. | TMO | Sr. VP and Chief HR Officer | Nov 12, 2025 | Sell | $588.27 | 1,057 | $622,135.53 | 13,087.227 | |
| Pettiti Gianluca | TMO | Executive Vice President | Nov 10, 2025 | Sell | $580.00 | 2,975 | $1,725,500.00 | 21,152.223 | |
| Britt Lisa P. | TMO | Sr. VP and Chief HR Officer | Nov 7, 2025 | Sell | $571.53 | 10,225 | $5,844,850.07 | 13,087.227 | |
| CASPER MARC N | TMO | Chairman & CEO | Oct 27, 2025 | Sell | $566.71 | 7,250 | $4,104,241.78 | 116,019.285 | |
| CASPER MARC N | TMO | Chairman & CEO | Oct 24, 2025 | Sell | $573.23 | 17,104 | $9,809,862.02 | 116,019.285 |
Latest Thermo Fisher Scientific Inc News
TMO Breaking Stock News: Dive into TMO Ticker-Specific Updates for Smart Investing
Insider Monkey
What Made Thermo Fisher Scientific (TMO) a Solid Performer in Q3?
📊
AI Sentiment
Positive
7/10
MT Newswires
Thermo Fisher Scientific Insider Sold Shares Worth $8,154,131, According to a Recent SEC Filing
➖
AI Sentiment
Neutral
5/10
Zacks
TMO Stock Benefits From New Bioprocess Design Center in Asia
📈
AI Sentiment
Highly Positive
8/10
MT Newswires
Thermo Fisher Scientific Expands Bioprocess Design Centers Across Asia
📊
AI Sentiment
Positive
6/10
Business Wire
Thermo Fisher Scientific Deepens Investment in Asia’s Biopharma Ecosystem with Expansion of Bioprocess Design Centers
📈
AI Sentiment
Highly Positive
8/10
Compare TMO vs Leading Stocks
See how TMO stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "TMO Thermo Fisher Scientific Inc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.